Bloomberg

Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg’s global leadership in business and financial news and data, with Quintillion Media’s deep expertise in the Indian market and digital news delivery, to provide high quality business news, insights and trends for India’s sophisticated audiences.

Stocks Radar: Aditya Birla Nuvo, CDSL, InterGlobe Aviation

Indian shares opened negative with the NSE Nifty 50 index and the S&P BSE Sensex index shedding 0.3 percent each, due to weak global cues from U.S and Europe.

The NSE Nifty 50 index fell below the 9,500 mark and was trading at 9465 while the Sensex opened below the 31,000 mark.

The advance-decline ratio was skewed in favour of the sellers. 1,020 stocks declined compared to 443 stocks that gained.

Here Are The Stocks Moving The Market This Morning:

CDSL: Big Bang Debut

Shares of the depository services provider began trading at Rs 250 each, above its IPO price of Rs 149 on the NSE. This represents a premium of nearly 68 percent. The stock rose another 7 percent to Rs 268 – its intraday high so far.

InterGlobe Aviation: Extends Decline

Shares of the low-cost carrier fell as much as 5.2 percent intraday, the most since February 01, after it confirmed expressing interest in buying a stake in debt-ridden Air India.

Trading volume was 6.3 times the 20-day average at around 10:00 a.m.

The budget carrier operated by InterGlobe Aviation Ltd. has written to the government that it’s keen to acquire the airline operations of Air India and its budget airline unit Air India Express Ltd., the company said in a filing Thursday. (For more details, click here)

The stock has fallen 5 times in six sessions, losing nearly 6 percent in that period.

Aditya Birla Nuvo: Azim Premji Picks Up Stake

Shares of the financial service provider rose as much as 4 percent to Rs 1,892 after Wipro founder Azim Premji’s investment arm agreed to buy a 2.2 percent stake in Aditya Birla Capital Ltd.

The company issued 4.84 crore equity shares at Rs 145.4 each, according to its exchange filing.

The Relative Strength Index (RSI) was 73, indicating that the stock may be overbought. The stock returned 42 percent so far this year and a gain of 50 percent in the past 52 weeks.

Dr. Reddy’s Laboratories: Receives Form 483

Shares of the drug maker fluctuated between gains and losses, after U.S. drug regulator issued a Form 483 with one observation for its Srikakulam plant.